The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review
Frontiers in Drug Safety and Regulation · 11.06.2026 · 6
DOI: 10.3389/fdsfr.2026.1825005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Drug Safety and Regulation, online erschienen am 11.06.2026. Verfasst von Hind B Alshalhoob und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Majmaah University, Al Majma'ah, Saudi Arabia. Die Arbeit nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drug-induced cutaneous phenotypes can act as early, bedside-visible clinical risk signals of systemic toxicity because the skin externalizes immune dysregulation, epithelial injury, and microvascular disturbance before organ-specific symptoms are obvious. This narrative review synthesizes peer-reviewed human evidence linking drug-related eruptions to systemic harm and actionable clinical decisions. We searched databases through January 2026 with citation chasing and organized findings using a morphology-anchored framework cross mapped to drug classes and mechanisms. High-risk patterns repeatedly signal urgent systemic risk: painful dusky or targetoid lesions with mucosal involvement and blistering/epidermal detachment require immediate culprit withdrawal and admission-level supportive care; widespread eruption with facial edema plus fever, lymphadenopathy, eosinophilia, or atypical lymphocytosis requires drug discontinuation and close monitoring for drug reaction with eosinophilia and systemic symptoms (DRESS). Research priorities include prospective validation of phenotypes as quantitative predictive risk signals, harmonized outcomes, reproducible imaging standards, and bias-aware digital implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, Majmaah University, Al Majma'ah, Saudi Arabia.
- Dermatology Department, King Salman Bin Abdulaziz Medical City, Madinah, Saudi Arabia.
- College of Medicine, King Faisal University, Al Ahsa, Saudi Arabia.
- Ministry of Health, Riyadh, Saudi Arabia.
- Dermatology Department, King Fahd Specialist Hospital, Buraydah, Saudi Arabia.
Zitieren
APA
Alshalhoob, H. B., Albelowi, L. M., Alotaibi, A. S., Alanazi, S. K., Alturki, L. E., Alsindi, Z. S., Alduraywish, W. A., Almulla, S. A., Almulla, A. A., Almagushi, N. A., & Alkhezzi, S. K. (2026). The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review. Frontiers in Drug Safety and Regulation, 6. https://doi.org/10.3389/fdsfr.2026.1825005
Vancouver
Alshalhoob HB, Albelowi LM, Alotaibi AS, Alanazi SK, Alturki LE, Alsindi ZS, et al. The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review. Frontiers in Drug Safety and Regulation. 2026;6. doi:10.3389/fdsfr.2026.1825005
BibTeX
@article{Alshalhoob2026,
author = {Alshalhoob, Hind B and Albelowi, Lama M and Alotaibi, Aseel S and Alanazi, Shada Khalid and Alturki, Leen E and Alsindi, Zahra Saleh and Alduraywish, Waad Abdulelah and Almulla, Sarah Anwar and Almulla, Ahmed Anwar and Almagushi, Nouf Abdulaziz and Alkhezzi, Sarah Khalifah},
title = {The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review},
journal = {Frontiers in Drug Safety and Regulation},
year = {2026},
volume = {6},
doi = {10.3389/fdsfr.2026.1825005}
}
EUVIMED